The effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS

[1]  T. Julian,et al.  Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. , 2011, Journal of the National Cancer Institute.

[2]  D. Sgroi,et al.  The molecular pathology of breast cancer progression , 2011, The Journal of pathology.

[3]  J. Brock,et al.  A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial , 2011 .

[4]  Stephen W Duffy,et al.  Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England , 2010, Journal of medical screening.

[5]  R. Kane,et al.  Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. , 2010, Journal of the National Cancer Institute.

[6]  P. Gøtzsche,et al.  Who evaluates public health programmes? A review of the NHS Breast Screening Programme , 2010, Journal of the Royal Society of Medicine.

[7]  M. Morrow,et al.  Clinical dilemma of ductal carcinoma in situ. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Peter C Gøtzsche,et al.  Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends , 2009, BMJ : British Medical Journal.

[9]  T. Tuttle,et al.  Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Steven Woloshin,et al.  The sea of uncertainty surrounding ductal carcinoma in situ--the price of screening mammography. , 2008, Journal of the National Cancer Institute.

[11]  M. J. van de Vijver,et al.  Immunohistochemical categorisation of ductal carcinoma in situ of the breast , 2007, British Journal of Cancer.

[12]  Paul W Dickman,et al.  Estimating and modeling the cure fraction in population-based cancer survival analysis. , 2007, Biostatistics.

[13]  H. Macdonald,et al.  Breast cancer-specific mortality after invasive local recurrence in patients with ductal carcinoma-in-situ of the breast. , 2006, American journal of surgery.

[14]  K. Mokbel,et al.  Heterogeneity of ductal carcinoma in situ and its effects on management. , 2006, The Lancet. Oncology.

[15]  S. Joslyn.  Ductal Carcinoma in Situ: Trends in Geographic, Temporal, and Demographic Patterns of Care and Survival , 2006, The breast journal.

[16]  W. Dupont,et al.  The natural history of low‐grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long‐term follow‐up , 2005, Cancer.

[17]  Jan Mæhlen,et al.  Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study , 2004, BMJ : British Medical Journal.

[18]  Karla Kerlikowske,et al.  Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy. , 2003, Journal of the National Cancer Institute.

[19]  M. Silverstein,et al.  Breast-conserving therapy for ductal carcinoma in situ: a 20-year experience with excision plus radiation therapy. , 2002, American journal of surgery.

[20]  S. Singletary,et al.  Standard for the Management of Ductal Carcinoma In Situ of the Breast (DCIS) , 2002, CA: a cancer journal for clinicians.

[21]  I. Ellis,et al.  Screen detected ductal carcinoma in situ (DCIS): overdiagnosis or an obligate precursor of invasive disease? , 2001, Journal of medical screening.

[22]  D. Schultz,et al.  Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status. , 2001, International journal of radiation oncology, biology, physics.

[23]  L Duchateau,et al.  Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  M. Silverstein,et al.  A prognostic index for ductal carcinoma in situ of the breast , 1996, Cancer.

[25]  D. Schultz,et al.  Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.